Studies have shown that using small interfering RNAs to knock down thioredoxin reductase 1 (TXNRD1) expression increases the basal level of reactive oxygen species and increases the sensitivity of lung cancer cells to radiotherapy [20]. This evidence concerns the gene TXNRD1 and lung cancer.